Health and Wellness : US Ebola Issues - and Patient Treatments

[Clyde C Coger Jr]

In the Spirit of Sankofa,



... He (the white doctor and the white female) was given ZMapp, Framily ... Its strange to me that the Liberian Doctor, Khan, was scheduled to receive the new drug, but it wasn't given; in fact, he wasn't even told about its existence, and of course he died recently

... In the end, the treating physicians decided against using the drug. They never told Khan of its existence because they felt it would be unethical to tell him of a treatment they might not use. Shortly after their decision, however, Khan's condition worsened, the statement said, and the company providing the medical evacuation decided not to transfer him. He died a few days later, on July 29 ...

US doctor with Ebola to be released from hospital soon

Washington (AFP) - The American doctor who became ill with the Ebola virus while treating patients in Liberia will be released from a US hospital soon, a Christian aid group said Thursday.

"Dr. Kent Brantly is doing very well and hopes to be released sometime in the near future," said a statement from Samaritan's Purse.

It did not give any specifics on timing.

The staff at Emory University hospital in Atlanta, Georgia "are taking extremely great care of him," the statement added.

http://news.yahoo.com/us-doctor-ebola-released-hospital-soon-174919099.html


Doctors: Ebola drug poses 'impossible dilemma'


DAKAR, Senegal (AP) — Doctors treating a Sierra Leone physician with Ebola defended their decision not to give him an experimental drug, saying Wednesday they feared it was too risky.

Calling it "an impossible dilemma," Doctors Without Borders explained in detail last month's decision in response to a New York Times story on the case. It would have been the first time the experimental drug was tried in humans.

The experimental drug, ZMapp, is designed to boost the immune system to help it fight the virus. Since Khan's body was already producing an immune response, the doctors may have feared that any boost would kick it into overdrive.

View gallery

In this photo taken on Tuesday, Aug. 12, 2014, Guinea soldiers stand around a rope across the road t …
In the end, the treating physicians decided against using the drug. They never told Khan of its existence because they felt it would be unethical to tell him of a treatment they might not use. Shortly after their decision, however, Khan's condition worsened, the statement said, and the company providing the medical evacuation decided not to transfer him. He died a few days later, on July 29.



http://news.yahoo.com/considered-ebola-drug-sierra-leone-doctor-124016817.html

 

[Clyde C Coger Jr]

In the Spirit of Update,




A Look at the Production of Ebola Drug

A unique variety of tobacco seedlings emerge in the greenhouse at Medicago USA, Inc. in Research Triangle Park, N.C. Through its plant-based technology, the facility is capable of producing millions of doses of vaccines. While most of the work in this area uses a tobacco plant, it's just a relative of the plant used to make cigarettes


It's an eye-catching angle in the story of an experimental treatment for Ebola: The drug comes from tobacco plants that were turned into living pharmaceutical factories.

Using plants this way - sometimes called "pharming" -- can produce complex and valuable proteins for medicines. That approach, studied for about 20 years, hasn't caught on widely in the pharmaceutical industry.

http://finance.yahoo.com/photos/a-look-at-the-production-of-ebola-drug-1408128508-slideshow/

 

[Clyde C Coger Jr]

In the Spirit of Update,




Liberia gets Ebola drug; ponders who should get it

Liberian policemen, right, dressed in riot gear disperse a crowd of people that blocked a main road after the body of someone suspected of dying from the Ebola virus was not removed by health workers in the city of Monrovia, Liberia. Thursday, Aug. 14, 2014. Liberia faced an excruciating choice Thursday: deciding which handful of Ebola patients will receive an experimental drug that could prove either life-saving or life-threatening. ZMapp, the untested Ebola drug, arrived in the West African country late Wednesday.



MONROVIA, Liberia • Liberian officials faced a difficult choice Thursday: deciding which handful of Ebola patients will receive an experimental drug that could prove life-saving, ineffective or even harmful.

ZMapp, the untested Ebola drug, arrived in the West African country late Wednesday. A day later, no one had received the treatment, which officials said would go to three people.

The government had previously said two doctors would receive the treatment, but it was unclear who else would. Information Minister Lewis Brown said Thursday it would probably be another health care worker.

These are the last known doses of ZMapp. The San Diego-based company that developed it has said it will take months to build up even a modest supply.

http://www.stltoday.com/news/world/...cle_8ccfc6c0-bc70-51bf-aaf4-c38826d0f36c.html

 

[dunwiddat]

Who will determine the ones to get it. I am sure this is going to be a great dilemma.

 

[Clyde C Coger Jr]

Good question, let's pray they find a solution.

Who will determine the ones to get it. I am sure this is going to be a great dilemma.